NCT00310180 2026-04-13
TAILORx
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
44 trialsNCT03414970 2026-02-24
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT05415215 2026-02-10
ProHer
Hoffmann-La Roche
Phase 3 Completed
NCT00066690 2026-02-06
SOFT
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT01796197 2026-02-05
Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa
Dana-Farber Cancer Institute
Phase 2 Completed
NCT03542175 2025-12-08
A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01750073 2025-11-18
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer
University of Nebraska
Phase 2 Active not recruiting
NCT02700386 2025-10-27
Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph Nodes
University of Colorado, Denver
Phase 2 Active not recruiting
NCT01819233 2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA Completed
NCT00838929 2025-05-04
Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases
Thomas Jefferson University
Phase 1 Completed
NCT00328783 2025-04-30
Using the Active Breathing Control Device to Reduce Radiation Side Effects to Critical Structures in Breast Cancer
Thomas Jefferson University
Phase NA Completed
NCT03691493 2025-02-17
ASPIRE
Emory University
Phase 2 Completed
NCT03422003 2024-11-01
Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma
Dana-Farber Cancer Institute
Phase NA Active not recruiting
NCT00182728 2024-10-01
NRR
UNC Lineberger Comprehensive Cancer Center
Phase NA Completed
NCT03324802 2024-05-02
Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery
Mayo Clinic
Phase 3 Completed
NCT00499083 2023-09-29
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)
University of Nebraska
Phase 2 Completed
NCT01242800 2023-06-29
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Eastern Cooperative Oncology Group
Phase NA Completed
NCT03137693 2023-02-23
Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Terminated
NCT02730130 2022-10-19
Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00377156 2022-09-16
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00542191 2021-05-26
Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer
Leo W. Jenkins Cancer Center
Phase 2 Terminated
NCT02280252 2020-11-23
Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response
NYU Langone Health
Phase 2 Completed
NCT00836186 2020-10-08
Cytokine Expression During Radiation for Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT00562718 2020-08-21
Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT01017549 2020-08-13
Post Market Study Using the Xoft Axxent System
Xoft, Inc.
Phase NA Completed
NCT00181363 2020-01-28
Prone Breast Irradiation for Pendulous Breasts
Maastricht Radiation Oncology
Phase NA Completed
NCT02538471 2019-12-09
LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer
Weill Medical College of Cornell University
Phase 2 Terminated
NCT01401062 2019-03-05
Fresolimumab and Radiotherapy in Metastatic Breast Cancer
Weill Medical College of Cornell University
Phase 2 Completed
NCT02297230 2018-10-15
Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics
NYU Langone Health
Phase 1/2 Terminated
NCT00053898 2018-09-20
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
NSABP Foundation Inc
Phase 3 Completed
NCT00916578 2018-07-26
Xeloda (Capecitabine) and External Beam Radiation
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02203565 2017-07-26
Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy
Stanford University
Phase 2 Completed
NCT00003199 2017-07-12
Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT00194792 2017-07-11
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer
University of Washington
Phase 2 Terminated
NCT01754519 2017-07-07
Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery
Roswell Park Cancer Institute
Phase 2 Terminated
NCT01868503 2017-06-26
Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer
Stanford University
Phase 2 Terminated
NCT00074152 2017-06-16
CALOR
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT00182793 2017-02-23
Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
City of Hope Medical Center
Phase 2 Completed
NCT01167192 2016-12-30
Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer
Washington University School of Medicine
Phase 2 Terminated
NCT00603408 2016-08-19
Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer
Washington University School of Medicine
Phase 2 Terminated
NCT00305643 2015-12-24
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00581113 2015-06-11
Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases
Virginia Commonwealth University
Phase 3 Terminated
NCT00119262 2014-05-15
Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00118053 2013-11-20
Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
Rutgers, The State University of New Jersey
Phase 2 Terminated